Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Income from Continuing Operations (2016 - 2025)

HealthLynked (HLYK) has disclosed Income from Continuing Operations for 10 consecutive years, with 735503.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 40.21% to 735503.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3086302.0 through Dec 2025, up 49.66% year-over-year, with the annual reading at 688900.0 for FY2025, 88.76% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 735503.0 at HealthLynked, roughly flat from 736654.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 161370.0 in Q3 2023, with the low at 7823453.0 in Q1 2021.
  • Average Income from Continuing Operations over 5 years is 1579972.6, with a median of 1204025.5 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations crashed 1248.37% in 2021, then surged 89.49% in 2023.
  • Over 5 years, Income from Continuing Operations stood at 2003004.0 in 2021, then crashed by 103.55% to 4077090.0 in 2022, then surged by 68.46% to 1285733.0 in 2023, then rose by 4.32% to 1230206.0 in 2024, then soared by 40.21% to 735503.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 735503.0, 736654.0, and 682780.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.